Clinical and laboratory features of patients
Characteristic . | All patients . | |
---|---|---|
n = 74 . | % . | |
Sex | ||
Male | 46 | 63 |
Female | 28 | 37 |
Light-chain type | ||
κ | 55 | 74 |
λ | 18 | 24 |
Biclonal | 1 | 2 |
B2-microglobulin > 2.7 (mg/L) | 24 of 39 | 62 |
Albumin < 3.5 (g/dL) | 23 of 46 | 50 |
Labeling index 1* (%) | 1 | 2 |
Hemoglobin < 11 | 47 of 73 | 64 |
BM clonal involvement (%) | 50 (median) | 5-95 (range) |
Characteristic . | All patients . | |
---|---|---|
n = 74 . | % . | |
Sex | ||
Male | 46 | 63 |
Female | 28 | 37 |
Light-chain type | ||
κ | 55 | 74 |
λ | 18 | 24 |
Biclonal | 1 | 2 |
B2-microglobulin > 2.7 (mg/L) | 24 of 39 | 62 |
Albumin < 3.5 (g/dL) | 23 of 46 | 50 |
Labeling index 1* (%) | 1 | 2 |
Hemoglobin < 11 | 47 of 73 | 64 |
BM clonal involvement (%) | 50 (median) | 5-95 (range) |
Includes plasma cells and lymphocyte clonal cells (defined by light-chain restriction).